Zung Jonathan B. 4/A
4/A · Evelo Biosciences, Inc. · Filed Feb 1, 2021
Insider Transaction Report
Form 4/AAmended
Zung Jonathan B.
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
[F1]2021-01-27+300,000→ 300,000 totalExercise: $16.65Exp: 2031-01-27→ Common Stock (300,000 underlying) - Award
Restricted Stock Units
[F2]2021-01-27+10,000→ 10,000 totalExercise: $0.00→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]This option will vest as to 25% of the total grant on January 4, 2022 and as to the remaining 75% vesting thereafter in thirty-six (36) substantially equal monthly installments, subject to continued employment on such dates.
- [F2]These Restricted Stock Units will vest in full on the third anniversary of the grant date, January 27, 2024, subject to continued employment on such date.
Signature
/s/ Daniel S. Char, Attorney-in-Fact for Jonathan B. Zung|2021-02-01